glp 1 prospect Multifaceted Roles of GLP-1 and Its Analogs: A Review on Molecular Mechanisms with a Cardiotherapeutic Perspective GLP-1 receptor agonists | How

Note : Approximately 70% of American adults are overweight or obese

Photo by Innerbody Research Weight loss is a struggle for most people

Supports balanced metabolic activity for everyday weight-management goals*

If the EVOKE trial results in late 2025 show clear benefits, it could take another one to two years for FDA approval and insurance coverage decisions

Appetite and food choices Food noise, portion size, cravings, protein consistency, and hydration are key context for GLP-1 users

For patients with severe obesity (BMI 40 or 35 with obesity-related complications), referral for evaluation of bariatric surgery may be appropriate according to American Society for Metabolic and Bariatric Surgery guidelines